Denice S Feig

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. pmc Preeclampsia as a risk factor for diabetes: a population-based cohort study
    Denice S Feig
    Department of Medicine, University of Toronto, Toronto, Canada
    PLoS Med 10:e1001425. 2013
  2. ncbi request reprint Preventing diabetes in women with gestational diabetes
    Denice Feig
    Departments of Medicine, Obstetrics and Gynecology, Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Mt Sinai Hospital, Toronto, Ontario, Canada
    Diabetes Metab Res Rev 28:305-6. 2012
  3. doi request reprint Avoiding the slippery slope: preventing the development of diabetes in women with a history of gestational diabetes
    Denice S Feig
    Departments of Medicine, Obstetrics and Gynecology, Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada
    Diabetes Metab Res Rev 28:317-20. 2012
  4. doi request reprint Breastfeeding predicts the risk of childhood obesity in a multi-ethnic cohort of women with diabetes
    Denice S Feig
    Department of Medicine, University of Toronto, Ontario, Canada
    J Matern Fetal Neonatal Med 24:511-5. 2011
  5. ncbi request reprint Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes: a population-based study in Ontario, Canada, 1996-2001
    Denice S Feig
    Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Diabetes Care 29:232-5. 2006
  6. ncbi request reprint Long-term effects of a diabetes and pregnancy program: does the education last?
    Denice S Feig
    Mount Sinai Hospital, 600 University Avenue, Lebovic Building, Suite 5027, Toronto, Ontario, Canada M5G 1X5
    Diabetes Care 29:526-30. 2006
  7. ncbi request reprint Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?
    Denice S Feig
    Department of Medicine, University of Toronto, Ontario, Canada
    Ann Pharmacother 41:1174-80. 2007
  8. doi request reprint Oral hypoglycemic therapy: understanding the mechanisms of transplacental transfer
    Erika K Pollex
    Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada
    J Matern Fetal Neonatal Med 23:224-8. 2010
  9. pmc Insulin glargine safety in pregnancy: a transplacental transfer study
    Erika K Pollex
    Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada
    Diabetes Care 33:29-33. 2010
  10. doi request reprint Effect of home blood pressure telemonitoring with self-care support on uncontrolled systolic hypertension in diabetics
    Alexander G Logan
    Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 435 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
    Hypertension 60:51-7. 2012

Collaborators

Detail Information

Publications23

  1. pmc Preeclampsia as a risk factor for diabetes: a population-based cohort study
    Denice S Feig
    Department of Medicine, University of Toronto, Toronto, Canada
    PLoS Med 10:e1001425. 2013
    ....
  2. ncbi request reprint Preventing diabetes in women with gestational diabetes
    Denice Feig
    Departments of Medicine, Obstetrics and Gynecology, Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada Mt Sinai Hospital, Toronto, Ontario, Canada
    Diabetes Metab Res Rev 28:305-6. 2012
    ..Copyright © 2012 John Wiley & Sons, Ltd...
  3. doi request reprint Avoiding the slippery slope: preventing the development of diabetes in women with a history of gestational diabetes
    Denice S Feig
    Departments of Medicine, Obstetrics and Gynecology, Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada
    Diabetes Metab Res Rev 28:317-20. 2012
    ..In this article, we review the evidence for different strategies used to prevent the onset of diabetes in women with a history of gestational diabetes. These strategies include lifestyle changes, medications and breastfeeding...
  4. doi request reprint Breastfeeding predicts the risk of childhood obesity in a multi-ethnic cohort of women with diabetes
    Denice S Feig
    Department of Medicine, University of Toronto, Ontario, Canada
    J Matern Fetal Neonatal Med 24:511-5. 2011
    ..To determine whether breastfeeding reduced the risk of childhood obesity in the infants of a multi-ethnic cohort of women with pregestational diabetes...
  5. ncbi request reprint Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes: a population-based study in Ontario, Canada, 1996-2001
    Denice S Feig
    Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Diabetes Care 29:232-5. 2006
    ..To describe recent trends in the proportion of deliveries in women with pregestational diabetes (PGD), their use of services, and diabetes-related obstetrical complications...
  6. ncbi request reprint Long-term effects of a diabetes and pregnancy program: does the education last?
    Denice S Feig
    Mount Sinai Hospital, 600 University Avenue, Lebovic Building, Suite 5027, Toronto, Ontario, Canada M5G 1X5
    Diabetes Care 29:526-30. 2006
    ..To determine whether women with pregestational diabetes obtained long-term benefits from an intensive diabetes management program during pregnancy...
  7. ncbi request reprint Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?
    Denice S Feig
    Department of Medicine, University of Toronto, Ontario, Canada
    Ann Pharmacother 41:1174-80. 2007
    ..To provide information on the use of oral antidiabetic agents in pregnancy and breast-feeding...
  8. doi request reprint Oral hypoglycemic therapy: understanding the mechanisms of transplacental transfer
    Erika K Pollex
    Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada
    J Matern Fetal Neonatal Med 23:224-8. 2010
    ..Therefore, it is essential that OHAs are further investigated to determine their safety with confidence and provide better treatment options for diabetes in pregnancy...
  9. pmc Insulin glargine safety in pregnancy: a transplacental transfer study
    Erika K Pollex
    Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada
    Diabetes Care 33:29-33. 2010
    ..Therefore, the objective of this study was to determine whether insulin glargine crosses the human placenta using the human perfused placental lobule technique...
  10. doi request reprint Effect of home blood pressure telemonitoring with self-care support on uncontrolled systolic hypertension in diabetics
    Alexander G Logan
    Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 435 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
    Hypertension 60:51-7. 2012
    ..Home blood pressure monitoring alone had no effect on blood pressure. Promoting patient self-care may have negative psychological effects...
  11. ncbi request reprint Transfer of insulin lispro across the human placenta: in vitro perfusion studies
    Rada Boskovic
    Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada
    Diabetes Care 26:1390-4. 2003
    ..Therefore, the objective of the present study was to examine whether insulin lispro crosses the placenta using the technique of perfusing a human placental lobule in vitro...
  12. pmc Risk of development of diabetes mellitus after diagnosis of gestational diabetes
    Denice S Feig
    Department of Medicine, University of Toronto, Toronto, Ont
    CMAJ 179:229-34. 2008
    ..However, the precise relation between these 2 conditions remains unknown. We sought to determine the incidence of diabetes mellitus after diagnosis of gestational diabetes...
  13. ncbi request reprint Maternal-fetal transport of hypoglycaemic drugs
    Facundo Garcia-Bournissen
    The Motherisk Program, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada
    Clin Pharmacokinet 42:303-13. 2003
    ....
  14. pmc Universal drug coverage and socioeconomic disparities in major diabetes outcomes
    Gillian L Booth
    Li Ka Shing Knowledge Institute of St Michael s Hospital, Toronto, Ontario, Canada
    Diabetes Care 35:2257-64. 2012
    ..We examined whether income disparities in diabetes-related morbidity or mortality decline after age 65 in a setting where much of health care is publicly funded yet universal drug coverage starts only at age 65...
  15. doi request reprint Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis
    Erika Pollex
    Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada
    Ann Pharmacother 45:9-16. 2011
    ..New insulin analogues such as the long-acting analogue insulin glargine may represent beneficial treatment options in pregnancy by ensuring that patients achieve excellent glycemic control without risk of maternal hypoglycemia...
  16. doi request reprint Pregnancy planning in women with pregestational diabetes
    Lorraine L Lipscombe
    Department of Medicine, Women s College Hospital, Toronto, Ontario, Canada
    J Matern Fetal Neonatal Med 24:1095-101. 2011
    ..We evaluated the adequacy of pregnancy planning effort and medical planning in pregnant women with type 1 and type 2 diabetes...
  17. ncbi request reprint Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients
    Alexander G Logan
    Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
    Am J Hypertens 20:942-8. 2007
    ..The objectives of this study were to develop and pilot-test a home BP tele-management system that actively engages patients in the process of care...
  18. pmc Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care
    Denice S Feig
    University of Toronto, Department of Medicine, Ont
    CMAJ 172:177-80. 2005
  19. ncbi request reprint Transfer of glyburide and glipizide into breast milk
    Denice S Feig
    Department of Medicine, University of Toronto, Toronto, Canada
    Diabetes Care 28:1851-5. 2005
    ..To determine if glyburide and glipizide are excreted into breast milk and if breast-feeding from women taking these drugs causes infant hypoglycemia...
  20. doi request reprint Iodine nutrition during pregnancy in toronto, Canada
    Pamela M Katz
    Department of Medicine, University of Manitoba, Winnipeg, MB, Canada
    Endocr Pract 19:206-11. 2013
    ..Conclusion: This cohort of primarily Caucasian, well-educated, and relatively affluent pregnant women in Toronto, Canada, are iodine sufficient, perhaps due to universal salt iodization and/or other dietary and lifestyle factors...
  21. doi request reprint False-positive meconium test results for fatty acid ethyl esters secondary to delayed sample collection
    Irene Zelner
    Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada
    Alcohol Clin Exp Res 36:1497-506. 2012
    ..This study investigated whether delayed sample collection can result in false-positive test results for FAEEs because of collection of samples potentially contaminated with postnatally produced stool...
  22. ncbi request reprint Type 2 diabetes in pregnancy: a growing concern
    Denice S Feig
    Division of Endocrinology and Metabolism, Mount Sinai Hospital, Ontario M5G 1X5, Toronto, Canada
    Lancet 359:1690-2. 2002
  23. ncbi request reprint The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis
    Sheryl J Gutzin
    Department of Medicine, Mount Sinai Hospital and University of Toronto
    Can J Clin Pharmacol 10:179-83. 2003
    ..To examine the relationship between first-trimester exposure to oral hypoglycemic agents (OHAs), congenital anomalies and neonatal mortality, accounting for the potential confounding effect of maternal glycemic control...